Who are Decadron's main competitors?

Direct comparators (same drug class / molecular target / therapeutic area): Dexamethasone Sodium Phosphate.

How often does this brief refresh?

Every 30 minutes from primary sources (FDA, EMA, MHRA, PMDA, ClinicalTrials.gov, USPTO). Subscribe to the RSS feed below for push alerts.

How do I get this as a recurring report?

Subscribe to /feed/ci/decadron.xml in any RSS reader (Feedly, Inoreader, NewsBlur). Every regulatory action, trial readout, or patent event lands in your feed automatically.

Last reviewed 2026-05-15 · How we verify

Decadron — Competitive Intelligence Brief

Decadron (Decadron) competitive landscape: 1 comparator, recent regulatory actions, upcoming PDUFA, patent timeline. Area: Other.

marketed Androgen receptor, Glucocorticoid receptor, Mineralocorticoid receptor Other Small molecule Live · refreshed every 30 min

Target snapshot

Decadron (Decadron) — University of Miami.

Comparator set (1 drugs)

Auto-detected by same drug class / molecular target / therapeutic area, ranked by phase + recency. Override with ?vs=slug1,slug2,….

Drug	Generic	Sponsor	Phase	Class	Target	Approval / PDUFA
Decadron TARGET	Decadron	University of Miami	marketed		Androgen receptor, Glucocorticoid receptor, Mineralocorticoid receptor
Dexamethasone Sodium Phosphate	dexamethasone phosphate	Merck & Co.	marketed	Corticosteroid	Androgen receptor, Glucocorticoid receptor, Mineralocorticoid receptor	1959-01-01

Recent regulatory actions (last 90 days)

No regulatory actions in the last 90 days for this set.

Upcoming PDUFA dates (next 180 days)

No PDUFA dates in the next 180 days for this set.

Patent timeline (forward window)

2030-02-12 — Dexamethasone Sodium Phosphate · 8563027 · Method of Use · US
2030-05-14 — Dexamethasone Sodium Phosphate · 8409606 · Formulation · US
2032-05-11 — Dexamethasone Sodium Phosphate · 10799642 · Formulation · US
2034-05-23 — Dexamethasone Sodium Phosphate · 10028965 · Method of Use · US
2034-05-23 — Dexamethasone Sodium Phosphate · 10159683 · Formulation · US
2034-06-22 — Dexamethasone Sodium Phosphate · 10022502 · Method of Use · US
2036-10-07 — Dexamethasone Sodium Phosphate · 12150896 · Method of Use · US
2037-11-16 — Dexamethasone Sodium Phosphate · 11458041 · Method of Use · US
2037-12-18 — Dexamethasone Sodium Phosphate · 11304961 · Formulation · US
2037-12-18 — Dexamethasone Sodium Phosphate · 10537585 · Formulation · US
2039-06-23 — Dexamethasone Sodium Phosphate · 11097061 · Formulation · US
2041-04-26 — Dexamethasone Sodium Phosphate · 12144889 · Method of Use · US

Sponsor landscape

No sponsor landscape data.

Subscribe to ongoing alerts

Push every new event for this competitive set into your RSS reader, IFTTT/Zapier workflow, or email digest:

Cite this brief

Drug Landscape (2026). Decadron — Competitive Intelligence Brief. https://druglandscape.com/ci/decadron. Accessed 2026-05-15.

Build your own brief

Pick any drug + add comparators:

https://druglandscape.com/ci/{slug} — auto-detected competitors
https://druglandscape.com/ci/{slug}?vs=drug1,drug2,drug3 — explicit comparators
Brand names auto-resolve: /ci/keytruda → 301 → /ci/pembrolizumab